Wound management accompanies a broad range of products and technologies, encompassing (especially in our report #S249) dressings (traditional adhesive, traditional gauze, non-adherents, films, foams, hydrogels, hydrocolloids, alginates, antimicrobials), negative pressure wound therapy, bioengineered skin & skin substitutes, and wound care growth factors.
While there are a great number of companies active in these wound management areas, a handful of companies stand out as leaders in the market. These companies have multiple product offerings, have the deep pockets needed to spend on research and development (as well as new product launch and marketing), have the in-house knowledge to develop novel treatments and devices and have the marketing know-how, distribution and other market strengths needed to succeed.
There are a great many companies active in wound care area because the barriers to entry for relatively low-tech products such as gauze and adhesive bandages are low, and the reward can be high. This is also a highly competitive market, much of which takes place in product pricing as the large, diversified companies are often able to cut price because of the volume that they have already captured. Especially for low-tech products, some key companies hold significant shares of each market, but below this, a large number of companies are able to eke out modest shares. In advanced wound care, however, there are considerably fewer companies, since these products require a high level of scientific expertise, research and development in order to create and manufacture products such as negative pressure wound therapy, bioengineered skin & skin substitutes and growth factors.
Source: MedMarket Diligence, LLC; Report #S249.